ArticleMolecular therapy oncolytics2016

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors.

Jan Rh Hanauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.